Parasiticidal formulations that can be applied dermally

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S341000, C514S830000

Reexamination Certificate

active

06372765

ABSTRACT:

The present invention relates to formulations for the dermal control of parasitic insects on animals by means of agonists or antagonists of the nicotinergic acetylcholine receptors of insects.
Agonists or antagonists of the nicotinergic acetylcholine receptors of insects are known. They include the nicotinyl insecticides and, very particularly, the chloronicotinyl insecticides.
PCT application WO 93/24 002 discloses that certain 1[N-(halo-3-pyridylmethyl)]-N-methylamino-1-alkylamino-2-nitroethylene derivatives are suitable for systemic use against fleas in domestic animals. According to WO 93/24 002, the nonsystemic—i.e. dermal—mode of application is unsuitable for the control of fleas on domestic animals.
New formulations for the dermal application of agonists or antagonists of the nicotinergic acetylcholine receptors of insects have now been found which are particularly suitable for dermal control of parasitic insects, such as fleas, lice or flies, on animals.
The formulations according to the invention have the following composition:
agonists or antagonists of the nicotinergic acetylcholine receptors of insects in a concentration of from 1 to 20% by weight based on the overall weight of the formulation;
solvents from the group benzyl alcohol or optionally substituted pyrrolidones in a concentration of at least 20% by weight based on the overall weight of the fomulation;
if desired, further solvents from the group consisting of cyclic carbonates or lactones in a concentration of from 5.0 up to 80% by weight based on the overall weight of the formulation;
if desired, further auxiliaries from the group thickeners, spreading agents, colorants, antioxidants, propellants, preservatives, adhesives, emulsifiers, in a concentration of from 0.025 up to 10% by weight based on the overall weight of the formulation.
Agonists or antagonists of the nicotinergic acetylcholine receptors of insects are known, for example, from European Offenlegungsschriften (European Published Applications) Nos. 464 830, 428 941, 425 978, 386 565, 383 091, 375 907, 364 844, 315 826, 259 738, 254 859, 235 725, 212 600, 192 060, 163 855, 154 178, 136 636, 303 570, 302 833, 306 696, 189 972, 455 000, 135 956, 471 372, 302 389; German Offenlegungsschriften (German Published Specifications) Nos. 3 639 877, 3 712 307; Japanese Offenlegungsschriften (Japanese Published Applications) Nos. 03 220 176, 02 207 083, 63 307 857, 63 287 764, 03 246 283, 04 9371, 03 279 359, 03 255 072, U.S. Pat. Nos. 5,034,524, 4,948,798, 4,918,086, 5,039,686, 5,034,404; PCT Applications Nos. WO 91/17 659, 91/4965; French Application No. 2 611 114; Brazilian Application No. 88 03 621.


REFERENCES:
patent: 4415563 (1983-11-01), Rajadhyaksha
patent: 5194264 (1993-03-01), Van Tonder
patent: 5712295 (1998-01-01), Mencke et al.
patent: 6001858 (1999-12-01), Sirinyan et al.
patent: 2331793 (1975-01-01), None
patent: 303490 (1989-02-01), None
patent: 433909 (1991-06-01), None
patent: 483052 (1992-04-01), None
patent: 590425 (1994-04-01), None
patent: 802111 (1958-10-01), None
patent: 2194147 (1988-03-01), None
patent: 2236250 (1991-04-01), None
patent: 93/24002 (1993-12-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Parasiticidal formulations that can be applied dermally does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Parasiticidal formulations that can be applied dermally, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Parasiticidal formulations that can be applied dermally will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2921090

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.